India News | Strict Action Will Be Taken Against Black Marketeers of Remdesivir: Anil Deshmukh

Get latest articles and stories on India at LatestLY. Maharashtra Home Minister Anil Deshmukh on Friday said that strict action will be taken against those involved in black marketing of Remdesivir and other medicine which are useful to treat COVID-19 patients.

India (File Image)

Mumbai (Maharashtra) [India], July 10 (ANI): Maharashtra Home Minister Anil Deshmukh on Friday said that strict action will be taken against those involved in black marketing of Remdesivir and other medicine which are useful to treat COVID-19 patients.

While speaking to the reporters Deshmukh said, "We have held a discussion with Food and Drug Administration Minister Dr Rajendra Shingne about curbing the black marketing of Remdesivir and other drugs needed to treat COVID-19 patients."

Also Read | PM Narendra Modi Expresses Grief Over Loss of Lives Due to Heavy Rain as well as Landslides in Arunachal Pradesh: Live News Breaking & Coronavirus Updates on July 10, 2020.

"Police and Food and Drug Administration will take strict action against those involved in black marketing of Remdesivir," added Deshmukh.

The minister also ensured that medicine like Remdesivir and other related medicine which are useful to treat COVID-19 patients will be supplied adequately.

Also Read | HBSE Class 10 Results 2020 Declared, Check Marks Online at bseh.org.in.

"Remdesiver injections will be available in large amount by Cipla and Hetero. The state government has initiated the process of purchasing the drug to make it available in hospitals across the state," he said.

On July 9, the Drugs Controller General of India (DCGI) has directed all three pharma giants--Cipla, Hetero, and Mylan to upload the details of anti-viral Remedsivir drug's supply on the firm's website respectively after witnessing the incidence of black marketing and overcharging of the injection above MRP.

Considering the emergency and unmet medical need for COVID -19 diseases, Central Drugs Standard Controller Organisation (CDSCO) -- the office of DCGI had granted permission to manufacture and market remedisvir injection able formulation for restricted emergency use in the country for the treatment of patients with COVID-19 infection subject to various conditions and restrictions.

According to the Union Health Ministry, the state has reported 2,30,599 COVID-19 cases including, 93,673 active cases, 1,27,259 recovered and 9,667 deaths so far. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)

Share Now

Share Now